Alacizumab (Anti-VEGFR2 / KDR / CD309)

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
Supplier Selleck Chemicals
Product # A3109
Sku # A3109-1mg
Pricing 1mg, $539.00
Feedback